Biopharma AI

Qure.ai Secures Landmark FDA Clearance for qXR-Detect, Cementing AI Leadership in Global Diagnostics—Brainlab Partnership Signals Agentic AI Workflow Revolution

Mumbai, India – March 4, 2026 – Qure.ai, a global leader in AI-powered radiology, today celebrated FDA clearance for…

ByByAnuja Singh Mar 4, 2026

Ardent Health’s Hellocare.ai Virtual Nursing Play: 20% Readmission Slash or AI Overreach in Care?

Ardent Health’s March 3-4, 2026, partnership with Hellocare.ai deploys AI modules for virtual nursing, telehealth, and real-time patient…

ByByAnuja Singh Mar 4, 2026

VA’s Nationwide Ambient AI Scribe Rollout: Burnout Buster or Documentation Digitized Trap?

The U.S. Department of Veterans Affairs on March 4, 2026, greenlit ambient scribe AI from Knowtex and Abridge…

ByByAnuja Singh Mar 4, 2026

AI in Clinical Trials: Breakthrough Efficiency or Bottlenecked by Biology’s Chaos?

AI is slashing clinical trial timelines and costs where data flows freely—think 35-50% faster enrollment and 30% OpEx…

ByByAnuja Singh Mar 3, 2026
Image Not Found

Is Insilico’s AI Drug Engine “Einstein” Turning China into the Global AI–Pharma Hub?

Insilico Medicine’s AI‑driven drug discovery platform, Pharma.AI “Einstein,” is scaling fast in China, with a major expansion of…

ByByAnuja Singh Mar 4, 2026

China Dominates 70% of Global AI Drug Patents: ADC/Bispecifics Surge or Innovation Bubble?

China Leads 70% of Global AI Drug Patents: Simple Strategic Snapshot China now holds 70% of the world’s…

ByByAnuja Singh Mar 4, 2026
Scroll to Top